BIOTECHNOLOGY VALUE FUND L P - 28 Jan 2026 SCHEDULE 13D/A Report for Repare Therapeutics Inc. Common Shares, no par value (RPTX)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BIOTECHNOLOGY VALUE FUND L P
Security
Repare Therapeutics Inc. Common Shares, no par value
Symbol
RPTX
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13D/A
Filing time
30 Jan 2026, 18:39:53 UTC
Date of event
28 Jan 2026
Previous filing
24 Nov 2025
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 0% 0 0 0 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0000918923
BVF I GP LLC 0% 0 0 0 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001803805
BIOTECHNOLOGY VALUE FUND II LP 0% 0 0 0 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001102444
BVF II GP LLC 0% 0 0 0 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001803806
Biotechnology Value Trading Fund OS LP 0% 0 0 0 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001660683
BVF Partners OS Ltd. 0% 0 0 0 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001660684
BVF GP HOLDINGS LLC 0% 0 0 0 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001803809
BVF PARTNERS L P/IL 0% 0 0 0 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001055947
BVF INC/IL 0% 0 0 0 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001056807
LAMPERT MARK N 0% 0 0 0 /s/ Mark N. Lampert Mark N. Lampert 0001233840